Insider transactions

Nicholas Galakatos

CIK 1252522 · last filed 2019-06-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
21
Total Filings
59
Lifetime Open-Market Net
-$11.27M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

AVNR price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
THE JOHN HANCOCK TOWER
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
Related Filers
Michael Steinmetz — 152 joint filings, latest 2016-02-10
Kurt Wheeler — 152 joint filings, latest 2018-07-02
Dennis Henner — 106 joint filings, latest 2018-07-02
Ansbert Gadicke — 80 joint filings, latest 2013-02-07
Luke Evnin — 65 joint filings, latest 2013-02-07
Robert Liptak — 56 joint filings, latest 2018-07-02
Nicholas J Simon III — 54 joint filings, latest 2016-09-29
Nicholas Simon — 54 joint filings, latest 2018-07-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Entasis Therapeutics Holdings Inc. (ETTX) Delisted Director 1,170,010 $2.19 $2.56M $6.80M 3 2019-06-21
NanoString Technologies Inc (NSTG) Delisted Director 4,036,025 $0.11 $425.0K -$1.37M 9 2019-03-27
Forty Seven, Inc. (FTSV) Delisted 10%+ Owner 938,489 — — $28.80M 1 2018-07-02
Astria Therapeutics, Inc. (CATB) Delisted Director 395,966 $8.54 $3.38M $4.52M 2 2016-08-05
TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted 10%+ Owner 4,332,775 — — -$773.8K 1 2016-01-28
IVERIC bio, Inc. (OPHT) Delisted Director 11,129 — — -$629.5K 11 2016-01-13
Oxford Immunotec Global PLC (OXFD) Delisted 10%+ Owner 2,334,854 — — -$4.17M 1 2015-06-03
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 3,468,494 $15.25 $52.89M $28.89M 1 2015-01-30
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 31,651 — — $0 4 2014-07-01
Pernix Sleep, Inc. (SOMX) Delisted 10%+ Owner 472,717 — — $63.7K 3 2012-06-19
AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Director 220,896 $15.00 $3.31M $0 3 2011-06-03
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted 10%+ Owner 8,246,414 — — -$71.37M 1 2010-11-05
SENORX INC (SENO) Delisted 10%+ Owner 2,032,475 — — -$22.81M 1 2010-06-29
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted 10%+ Owner 14,633,961 — — $0 1 2010-01-04
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 4,942,067 — — -$10.49M 1 2009-12-23
AFFYMAX INC (AFFY) Delisted Director — — — $0 3 2009-05-29
Pharmasset Inc (VRUS) Delisted 10%+ Owner 5,199 — — -$1.43M 2 2008-02-22
Altimmune, Inc. (HAQ.WS) Delisted 10%+ Owner 3,468,250 — — $6.74M 1 2007-08-07
HELICOS BIOSCIENCES CORP (HLCS) Delisted 10%+ Owner 2,987,769 — — $21.00M 1 2007-05-31
CRYOCOR INC (CRYO) Delisted 10%+ Owner 3,028,082 — — $4.96M 1 2007-04-25
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Director 963 $1.95 $1.9K $0 2 2007-02-15

Recent Filings · Page 3 of 6

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-05-28 IVERIC bio, Inc. (OPHT) Delisted Other (J) −1,544,288 $0 EDGAR
2015-01-30 AERIE PHARMACEUTICALS INC (AERI) Delisted Mixed +2,889,000 $28.89M EDGAR
2015-01-05 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
2014-07-01 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Grant (A) — $0 EDGAR
2014-03-27 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Other (J) +1,369 $0 EDGAR
2014-01-03 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
2013-11-20 IVERIC bio, Inc. (OPHT) Delisted Buy (P) +5,000 $110.0K EDGAR
2013-10-25 IVERIC bio, Inc. (OPHT) Delisted Grant (A) — $0 EDGAR
2013-10-02 IVERIC bio, Inc. (OPHT) Delisted Conv (C) +24,555,600 $0 EDGAR
2013-07-12 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
Showing 21–30 of 59
Page 3 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.